Merck (MRK) is reportedly planning to double the production of molnupiravir, an antiviral COVID pill, next year. The Financial Times reported the drugmaker has secured deals to provide COVID ...

with Merck's being 40 pills and Pfizer's being 30 pills. "As new variants of the virus continue to emerge, it is crucial to expand the country's arsenal of COVID-19 therapies using emergency use ...

Efforts to find an easy, early COVID-19 treatment ... who got the drug were hospitalized in the same time period. None died, officials with the pharmaceutical company Merck announced October ...

By Manas Mishra and Michael Erman (Reuters) -Merck & Co said on Friday updated data from its study of its experimental COVID ... Pills like molnupiravir and Paxlovid could be promising new weapons ...

which has been keenly anticipated as the first drug therapy for mild to moderate COVID-19 that can be delivered outside the hospital. Merck, which is known as MSD outside the US and Canada ...

Pfizer said Friday that a clinical trial of its first pill to treat Covid ... that Pfizer will stop recruiting new people for the trial, the company said. Coronavirus: Chinese toddler tested ...

The government has approved oral COVID-19 pills by Pfizer and Merck, both U.S. companies. However, they are only prescribed for COVID-19 patients at risk of developing serious symptoms as the ...

(JTA) — Israel’s government reached an agreement to buy tens of thousands of doses of Pfizer’s experimental new ... and Merck’s pill, called Molnupiravir, both work to stop the COVID ...